{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:56Z","timestamp":1788952436125,"version":"build-2803163510"},"reference-count":155,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2023-MSLH-159"],"award-info":[{"award-number":["2023-MSLH-159"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2024JH2\/102600173"],"award-info":[{"award-number":["2024JH2\/102600173"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2024-17-1"],"award-info":[{"award-number":["320.6750.2024-17-1"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025-17-28"],"award-info":[{"award-number":["320.6750.2025-17-28"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025-13-101"],"award-info":[{"award-number":["320.6750.2025-13-101"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.isci.2026.114877","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:35:45Z","timestamp":1770078945000},"page":"114877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metformin in gastrointestinal cancers and inflammatory bowel disease: Unraveling its mechanisms and therapeutic applications"],"prefix":"10.1016","volume":"29","author":[{"given":"Yanxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingqi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4736-2882","authenticated-orcid":false,"given":"Zhexian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.114877_bib1","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2026.114877_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.43333","article-title":"Type 2 Diabetes and Colorectal Cancer Risk","volume":"6","author":"Lawler","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2026.114877_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1747326","article-title":"Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications","volume":"2022","author":"Yu","year":"2022","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.isci.2026.114877_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.114877_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2337\/diacare.12.8.553","article-title":"Traditional plant medicines as treatments for diabetes","volume":"12","author":"Bailey","year":"1989","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.114877_bib6","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: clinical use in type 2 diabetes","volume":"60","author":"Sanchez-Rangel","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2026.114877_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin--mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.isci.2026.114877_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1445-5994.1991.tb01375.x","article-title":"Metformin increases insulin sensitivity and basal glucose clearance in type 2 (non-insulin dependent) diabetes mellitus","volume":"21","author":"McIntyre","year":"1991","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.isci.2026.114877_bib9","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.114877_bib10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2169\/internalmedicine.52.8276","article-title":"Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan","volume":"52","author":"Chiu","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.isci.2026.114877_bib11","article-title":"Diabetes and risk of cancer","volume":"2013","author":"Habib","year":"2013","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib12","first-page":"263","article-title":"Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies","volume":"23","author":"Huang","year":"2012","journal-title":"Cancer Causes Control."},{"key":"10.1016\/j.isci.2026.114877_bib13","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: a meta-analysis","volume":"97","author":"Larsson","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2026.114877_bib14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/hep.30083","article-title":"Diabetes, Plasma Glucose, and Incidence of Fatty Liver, Cirrhosis, and Liver Cancer: A Prospective Study of 0.5 Million People","volume":"68","author":"Pang","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.114877_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/dc14-1175","article-title":"The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity","volume":"38","author":"Peeters","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.114877_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/1759-7714.14756","article-title":"Addition of metformin to non-small-cell lung cancer patients with or without diabetes","volume":"14","author":"Chen","year":"2023","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.21037\/jtd-24-1152","article-title":"Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer-insights from two-sample Mendelian randomization study and meta-analysis","volume":"17","author":"Lin","year":"2025","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.isci.2026.114877_bib18","article-title":"Metformin Therapy and Breast Cancer Incidence in the Ha'il Region","volume":"11","author":"Osman","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.isci.2026.114877_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s44276-023-00022-w","article-title":"Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps","volume":"1","author":"Saito","year":"2023","journal-title":"BJC Rep."},{"key":"10.1016\/j.isci.2026.114877_bib20","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.3390\/curroncol29120758","article-title":"Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study","volume":"29","author":"Spoerl","year":"2022","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008860","article-title":"Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus","volume":"7","author":"Tseng","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.isci.2026.114877_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ijcard.2011.10.141","article-title":"Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community","volume":"166","author":"Romero","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.isci.2026.114877_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179738","article-title":"From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease","volume":"23","author":"Poznyak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114877_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12882-017-0579-5","article-title":"Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study","volume":"18","author":"Bell","year":"2017","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.isci.2026.114877_bib25","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.4254\/wjh.v7.i12.1652","article-title":"Systematic review: Preventive and therapeutic applications of metformin in liver disease","volume":"7","author":"Bhat","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.isci.2026.114877_bib26","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.7150\/thno.71360","article-title":"Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.114877_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/1940-6207.CAPR-08-0081","article-title":"The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase","volume":"1","author":"Zakikhani","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.isci.2026.114877_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16149-z","article-title":"Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production","volume":"7","author":"Mogavero","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.114877_bib29","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.230021","article-title":"Elevated basal AMP-activated protein kinase activity sensitizes colorectal cancer cells to growth inhibition by metformin","volume":"13","author":"Morrison","year":"2023","journal-title":"Open Biol."},{"key":"10.1016\/j.isci.2026.114877_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-022-04649-4","article-title":"Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-beta\/PI3K\/AKT signaling transduction","volume":"13","author":"Xiao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.114877_bib31","doi-asserted-by":"crossref","first-page":"13012","DOI":"10.1073\/pnas.1918845117","article-title":"Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1","volume":"117","author":"Xie","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.114877_bib32","doi-asserted-by":"crossref","first-page":"59503","DOI":"10.18632\/oncotarget.11147","article-title":"Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.114877_bib33","first-page":"1035","article-title":"Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer","volume":"41","author":"Chen","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2026.114877_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/carcin\/bgy008","article-title":"14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma","volume":"39","author":"Ding","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.isci.2026.114877_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12263-015-0499-6","article-title":"Metformin and soybean-derived bioactive molecules attenuate the expansion of stem cell-like epithelial subpopulation and confer apoptotic sensitivity in human colon cancer cells","volume":"10","author":"Montales","year":"2015","journal-title":"Genes Nutr."},{"key":"10.1016\/j.isci.2026.114877_bib36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12885-016-2157-9","article-title":"Combination of metformin and 5-aminosalicylic acid cooperates to decrease proliferation and induce apoptosis in colorectal cancer cell lines","volume":"16","author":"Saber","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1120009X.2022.2091122","article-title":"Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways","volume":"35","author":"Sun","year":"2023","journal-title":"J. Chemother."},{"key":"10.1016\/j.isci.2026.114877_bib38","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1038\/s41598-022-06587-9","article-title":"A functional screen with metformin identifies microRNAs that regulate metabolism in colorectal cancer cells","volume":"12","author":"Orang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.114877_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/genes12020245","article-title":"Negative Regulation of ULK1 by microRNA-106a in Autophagy Induced by a Triple Drug Combination in Colorectal Cancer Cells In Vitro","volume":"12","author":"Salgado-Garcia","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.isci.2026.114877_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/ERC-09-0252","article-title":"Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase","volume":"17","author":"Algire","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1134\/S0012496616030017","article-title":"Metformin inhibits development of colon malignant tumors induced by 1,2-dimethylhydrazine in rats","volume":"468","author":"Bekusova","year":"2016","journal-title":"Dokl. Biol. Sci."},{"key":"10.1016\/j.isci.2026.114877_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.20892\/j.issn.2095-3941.2016.0088","article-title":"Metformin prevents hormonal and metabolic disturbances and 1,2-dimethylhydrazine-induced colon carcinogenesis in non-diabetic rats","volume":"14","author":"Bekusova","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.isci.2026.114877_bib43","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mc.20637","article-title":"Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase","volume":"49","author":"Hosono","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.isci.2026.114877_bib44","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/cam4.521","article-title":"Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect","volume":"4","author":"Jia","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2026.114877_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124838","article-title":"Modified mesoporous silica nanocarriers containing superparamagnetic iron oxide nanoparticle, 5-fluorouracil or oxaliplatin, and metformin as a radiosensitizer, significantly impact colorectal cancer radiation therapy","volume":"666","author":"Khalili-Hezarjaribi","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.114877_bib46","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jgh.12435","article-title":"Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer","volume":"29","author":"Koh","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.114877_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100562","article-title":"Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation","volume":"9","author":"Zaafar","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib48","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.114877_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/2326-6066.CIR-16-0103","article-title":"Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia","volume":"5","author":"Scharping","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.isci.2026.114877_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101498","article-title":"Metformin-induced reductions in tumor growth involves modulation of the gut microbiome","volume":"61","author":"Broadfield","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.isci.2026.114877_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","article-title":"Microbiota-Derived Short-Chain Fatty Acids Promote the Memory Potential of Antigen-Activated CD8(+) T Cells","volume":"51","author":"Bachem","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.114877_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12032-022-01722-y","article-title":"Metformin inhibits the development and metastasis of colorectal cancer","volume":"39","author":"Sugiura","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib53","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","article-title":"Metformin Reprograms Tryptophan Metabolism to Stimulate CD8+ T-cell Function in Colorectal Cancer","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.114877_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00280-016-3037-3","article-title":"Combinational strategies of metformin and chemotherapy in cancers","volume":"78","author":"Zhang","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.isci.2026.114877_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41435-023-00234-7","article-title":"Metformin facilitates anti-PD-L1 efficacy through the regulation of intestinal microbiota","volume":"25","author":"Zhao","year":"2024","journal-title":"Genes Immun."},{"key":"10.1016\/j.isci.2026.114877_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/1940-6207.CAPR-14-0128","article-title":"Combined use of vitamin D3 and metformin exhibits synergistic chemopreventive effects on colorectal neoplasia in rats and mice","volume":"8","author":"Li","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.isci.2026.114877_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084369","article-title":"Metformin: a potential therapeutic agent for recurrent colon cancer","volume":"9","author":"Nangia-Makker","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70508","article-title":"Targeting Cancer Stem Cells and Hedgehog Pathway: Enhancing Cisplatin Efficacy in Ovarian Cancer With Metformin","volume":"29","author":"Jafarzadeh","year":"2025","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.isci.2026.114877_bib59","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1158\/1535-7163.MCT-16-0793","article-title":"Metformin Inhibits Cellular Proliferation and Bioenergetics in Colorectal Cancer Patient-Derived Xenografts","volume":"16","author":"Mohamed Suhaimi","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2026.114877_bib60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.5604\/01.3001.0010.3801","article-title":"Metformin - its potential anti-cancer and anti-aging effects","volume":"71","author":"Podhorecka","year":"2017","journal-title":"Postepy Hig. Med. Dosw."},{"key":"10.1016\/j.isci.2026.114877_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9312149","article-title":"Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU","volume":"2020","author":"Sang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.isci.2026.114877_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/0897190015627255","article-title":"Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies","volume":"30","author":"Nimako","year":"2017","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.isci.2026.114877_bib79","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/jgh.13639","article-title":"Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis","volume":"32","author":"Jung","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2026.114877_bib63","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","article-title":"Type 2 Diabetes and Cancer: An Umbrella Review of Observational and Mendelian Randomization Studies","volume":"30","author":"Pearson-Stuttard","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.isci.2026.114877_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11892-017-0829-8","article-title":"Metformin: New Preparations and Nonglycemic Benefits","volume":"17","author":"Fujita","year":"2017","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.isci.2026.114877_bib65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3748\/wjg.v27.i14.1362","article-title":"How far along are we in revealing the connection between metformin and colorectal cancer?","volume":"27","author":"Berkovic","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.114877_bib66","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.18632\/oncotarget.13762","article-title":"Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.114877_bib67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1158\/1055-9965.EPI-17-0424","article-title":"A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus","volume":"27","author":"Bradley","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.isci.2026.114877_bib68","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tranon.2018.02.012","article-title":"Dose-Dependent Relationship Between Metformin and Colorectal Cancer Occurrence Among Patients with Type 2 Diabetes-A Nationwide Cohort Study","volume":"11","author":"Chang","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib69","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1158\/1940-6207.CAPR-10-0186","article-title":"Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial","volume":"3","author":"Hosono","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.isci.2026.114877_bib70","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.114877_bib71","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jdiacomp.2013.04.010","article-title":"Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy","volume":"27","author":"Kanadiya","year":"2013","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.isci.2026.114877_bib72","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib73","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1080\/13880209.2016.1176057","article-title":"Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis","volume":"54","author":"Nie","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.isci.2026.114877_bib74","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/dom.12036","article-title":"Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus","volume":"15","author":"Qiu","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.isci.2026.114877_bib75","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3389\/fonc.2016.00210","article-title":"Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain","volume":"6","author":"Rosato","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib76","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cncr.29165","article-title":"Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population","volume":"121","author":"Sehdev","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib77","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-12-0369","article-title":"Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan","volume":"167","author":"Tseng","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.isci.2026.114877_bib78","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/cam4.306","article-title":"Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study","volume":"3","author":"Cardel","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.isci.2026.114877_bib80","first-page":"321","article-title":"Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal Cancer","volume":"15","author":"Miranda","year":"2016","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib81","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1634\/theoncologist.2016-0153","article-title":"Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)","volume":"21","author":"Singh","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.isci.2026.114877_bib82","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/1055-9965.EPI-11-0992-T","article-title":"Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis","volume":"21","author":"Bodmer","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.isci.2026.114877_bib83","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.isci.2026.114877_bib84","article-title":"Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib85","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2407-14-314","article-title":"Metformin induces an intracellular reductive state that protects oesophageal squamous cell carcinoma cells against cisplatin but not copper-bis(thiosemicarbazones)","volume":"14","author":"Damelin","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib86","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3892\/ijo.2012.1722","article-title":"Antitumor effect of metformin in esophageal cancer: in vitro study","volume":"42","author":"Kobayashi","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib87","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1159\/000354517","article-title":"Metformin inhibits esophagus cancer proliferation through upregulation of USP7","volume":"32","author":"Xu","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.isci.2026.114877_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.59","article-title":"Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling","volume":"5","author":"Feng","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.114877_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/carcin\/bgy160","article-title":"Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK\/mTOR signaling pathway","volume":"40","author":"Fan","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.isci.2026.114877_bib90","first-page":"2939","article-title":"Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway","volume":"15","author":"He","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2026.114877_bib91","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1159\/000495539","article-title":"Metformin Inhibited Growth, Invasion and Metastasis of Esophageal Squamous Cell Carcinoma in Vitro and in Vivo","volume":"51","author":"Liang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.isci.2026.114877_bib92","doi-asserted-by":"crossref","first-page":"74673","DOI":"10.18632\/oncotarget.20341","article-title":"Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK\/STAT3 signaling pathway","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.114877_bib93","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000365592","article-title":"Screening of alternative drugs to the tumor suppressor miR-375 in esophageal squamous cell carcinoma using the connectivity map","volume":"87","author":"Isozaki","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.isci.2026.114877_bib94","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13046-021-01834-9","article-title":"Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10","volume":"40","author":"Chen","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.114877_bib95","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2019.02.014","article-title":"Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497\/PELP1 axis","volume":"450","author":"Wang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.114877_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.762523","article-title":"Metformin Downregulates PD-L1 Expression in Esophageal Squamous Cell Catrcinoma by Inhibiting IL-6 Signaling Pathway","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib97","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/postgradmedj-2021-140432","article-title":"Is metformin use associated with a reduced risk of oesophageal cancer? A systematic review and meta-analysis","volume":"98","author":"Chen","year":"2022","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.isci.2026.114877_bib98","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071583","article-title":"Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review","volume":"8","author":"Franciosi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib99","article-title":"Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis","volume":"20","author":"Xie","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pcd.2020.06.001","article-title":"Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2021","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.isci.2026.114877_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102438","article-title":"The clinical potentials of combining paclitaxel-based chemotherapy regimen with metformin in cancer treatment: A systematic review and Meta-analysis","volume":"59","author":"Omidi Sarajar","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib102","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12094-020-02415-6","article-title":"The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"23","author":"Wu","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","article-title":"The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo","volume":"11","author":"Kato","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2026.114877_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153740","article-title":"Metformin and MiR-365 synergistically promote the apoptosis of gastric cancer cells via MiR-365-PTEN-AMPK axis","volume":"230","author":"Huang","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.isci.2026.114877_bib105","first-page":"1271","article-title":"Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR\/AKT signaling","volume":"54","author":"Lu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib106","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/15384047.2014.987021","article-title":"AMPK\/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell","volume":"16","author":"Han","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.isci.2026.114877_bib107","first-page":"321","article-title":"Combination of metformin and oxaliplatin inhibits gastric cancer cell proliferation and induces apoptosis","volume":"69","author":"Zhu","year":"2022","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.isci.2026.114877_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101946","article-title":"Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review","volume":"45","author":"Jalali","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.114877_bib109","doi-asserted-by":"crossref","DOI":"10.1186\/s41021-023-00296-z","article-title":"Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12","volume":"46","author":"Chen","year":"2024","journal-title":"Genes Environ."},{"key":"10.1016\/j.isci.2026.114877_bib110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejca.2017.07.020","article-title":"Metformin targets gastric cancer stem cells","volume":"84","author":"Courtois","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.114877_bib111","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1158\/0008-5472.CAN-09-2994","article-title":"Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission","volume":"69","author":"Hirsch","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.114877_bib112","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.21873\/anticanres.12982","article-title":"The Antitumor Effects of Metformin on Gastric Cancer In Vitro and on Peritoneal Metastasis","volume":"38","author":"Sekino","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.isci.2026.114877_bib113","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3892\/or.2015.4191","article-title":"Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models","volume":"34","author":"Jun","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2026.114877_bib114","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1002\/jcp.27269","article-title":"Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.isci.2026.114877_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174486","article-title":"Metformin inhibits gastric cancer cells metastatic traits through suppression of epithelial-mesenchymal transition in a glucose-independent manner","volume":"12","author":"Valaee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib116","doi-asserted-by":"crossref","first-page":"6188","DOI":"10.18632\/oncotarget.6748","article-title":"Negative regulation of Bmi-1 by AMPK and implication in cancer progression","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.114877_bib117","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/SLA.0000000000001086","article-title":"Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy","volume":"263","author":"Lee","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.isci.2026.114877_bib118","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5009\/gnl210132","article-title":"Chemopreventive Effect of Metformin on Gastric Cancer Development","volume":"16","author":"Cheung","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.isci.2026.114877_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214163","article-title":"Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk","volume":"23","author":"Lan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.114877_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/biom11071022","article-title":"The Relationship between Diabetes Mellitus and Gastric Cancer and the Potential Benefits of Metformin: An Extensive Review of the Literature","volume":"11","author":"Tseng","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2026.114877_bib121","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.tips.2020.09.001","article-title":"Metformin and Systemic Metabolism","volume":"41","author":"He","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2026.114877_bib122","first-page":"37","article-title":"Endocrine and metabolic manifestations in inflammatory bowel disease","volume":"25","author":"Tigas","year":"2012","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.isci.2026.114877_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121538","article-title":"Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus","volume":"15","author":"Tseng","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2026.114877_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/ph16050679","article-title":"Rosiglitazone Does Not Affect the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwanese Type 2 Diabetes Patients","volume":"16","author":"Tseng","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2026.114877_bib125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/path.1824","article-title":"Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease","volume":"207","author":"Szanto","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2026.114877_bib126","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/00365520310005055","article-title":"Redox imbalance in the colonic mucosa of ulcerative colitis","volume":"38","author":"Tsunada","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.114877_bib127","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10787-020-00730-6","article-title":"Novel complementary coloprotective effects of metformin and MCC950 by modulating HSP90\/NLRP3 interaction and inducing autophagy in rats","volume":"29","author":"Saber","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.isci.2026.114877_bib128","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1021\/acs.molpharmaceut.8b00332","article-title":"Metformin Protects against LPS-Induced Intestinal Barrier Dysfunction by Activating AMPK Pathway","volume":"15","author":"Wu","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2026.114877_bib129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fcell.2015.00062","article-title":"Mitochondrial dysfunction in inflammatory bowel disease","volume":"3","author":"Novak","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2026.114877_bib130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/15384047.2018.1529108","article-title":"Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice","volume":"20","author":"Wang","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.isci.2026.114877_bib131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.114877_bib132","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.0.CO;2-A","article-title":"Effect of metformin on bile salt circulation and intestinal motility in type 2 diabetes mellitus","volume":"15","author":"Scarpello","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.isci.2026.114877_bib133","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2337\/dc16-1324","article-title":"Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut","volume":"40","author":"de la Cuesta-Zuluaga","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.114877_bib134","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2026.114877_bib135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.114877_bib136","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.114877_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109230","article-title":"Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic","volume":"112","author":"Wanchaitanawong","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.114877_bib138","article-title":"Metformin Affects Gut Microbiota Composition and Diversity Associated with Amelioration of Dextran Sulfate Sodium-Induced Colitis in Mice","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.114877_bib139","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cmet.2017.09.019","article-title":"Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway","volume":"27","author":"Bauer","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.114877_bib140","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jconrel.2024.12.041","article-title":"The inflammatory bowel disease and gut microbiome are restored by employing metformin-loaded alginate-shelled microcapsules","volume":"378","author":"Kim","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.114877_bib141","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3389\/fphar.2018.00761","article-title":"Activating AMPK to Restore Tight Junction Assembly in Intestinal Epithelium and to Attenuate Experimental Colitis by Metformin","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.114877_bib142","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/08923973.2021.1878214","article-title":"Metformin alleviates inflammation in oxazolone induced ulcerative colitis in rats: plausible role of sphingosine kinase 1\/sphingosine 1 phosphate signaling pathway","volume":"43","author":"El-Mahdy","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.isci.2026.114877_bib143","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/10520295.2020.1776896","article-title":"Metformin alleviates experimental colitis in mice by up-regulating TGF-beta signaling","volume":"96","author":"Liu","year":"2021","journal-title":"Biotech. Histochem."},{"key":"10.1016\/j.isci.2026.114877_bib144","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ibd.20539","article-title":"Intestinal barrier dysfunction in inflammatory bowel diseases","volume":"15","author":"McGuckin","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2026.114877_bib145","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jcmm.13342","article-title":"Metformin protects against intestinal barrier dysfunction via AMPKalpha1-dependent inhibition of JNK signalling activation","volume":"22","author":"Deng","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.isci.2026.114877_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168670","article-title":"Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice","volume":"11","author":"Xue","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.114877_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/cells11040590","article-title":"Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis","volume":"11","author":"Olivier","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.114877_bib148","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/gut.2006.094375","article-title":"Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease","volume":"56","author":"Zeissig","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.114877_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.726707","article-title":"Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis","volume":"12","author":"Ke","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.114877_bib150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjaa136","article-title":"Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus","volume":"15","author":"Tseng","year":"2021","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.isci.2026.114877_bib151","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00535-022-01896-2","article-title":"Metformin use is not associated with reduced risk of older onset inflammatory bowel disease: a Danish nationwide population-based study","volume":"57","author":"Allin","year":"2022","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.114877_bib152","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ibd\/izae147","article-title":"Metformin Is Associated With Improved Inflammatory Bowel Disease Outcomes in Patients With Type 2 Diabetes Mellitus: A Propensity-Matched Cohort Study","volume":"31","author":"Petrov","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.isci.2026.114877_bib153","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: From molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.isci.2026.114877_bib154","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3892\/ol.2014.2158","article-title":"Metformin inhibits histone H2B monoubiquitination and downstream gene transcription in human breast cancer cells","volume":"8","author":"Du","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.isci.2026.114877_bib155","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/onc.2016.391","article-title":"Metformin alters DNA methylation genome-wide via the H19\/SAHH axis","volume":"36","author":"Zhong","year":"2017","journal-title":"Oncogene"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422600252X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422600252X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:30:03Z","timestamp":1788949803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258900422600252X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":155,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S258900422600252X"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.114877","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin in gastrointestinal cancers and inflammatory bowel disease: Unraveling its mechanisms and therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.114877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114877"}}